Imagine a beam of light that doesn’t burn—but heals.

A therapy that energises the body from within, rather than overriding it. This is the future of health optimisation, brain performance, and longevity—where photochemical science is redefining what’s possible.

A New Era in Wellness

Erchonia unveils its most advanced wellness innovation yet: the FX Series, a breakthrough synergy of multilayer, non-thermal lasers designed to optimise cellular health and performance.

Introducing: The FX Series & Precision Handheld Lasers

At the intersection of science and wellness, Erchonia presents a next-generation platform of non-thermal, high-energy lasers—including the hands-free FX Series and handheld systems like the EVRL, GVL, and XLR8—redefining laser therapy not as heat or damage, but as a biological catalyst.

“This is not heat—this is healing.”

From Photothermal to Photochemical

Unlike traditional lasers that rely on heat and tissue destruction, Erchonia’s non-thermal lasers use visible light to activate photochemical responses in cells. By targeting mitochondria—the body's energy centres—they help restore vitality, support hormonal balance, improve cognition, and build systemic resilience.

Why Mitochondria Matter

Mitochondria produce ATP, the body’s cellular fuel. But chronic stress, ageing, and modern life can impair their function. Mitochondrial dysfunction has been linked to:

• Hormonal imbalances (e.g. perimenopause, menopause)

• Chronic fatigue and inflammation

• Cognitive decline and weakened immunity

Colour as a Biological Strategy

Erchonia’s laser technology uses distinct wavelengths to deliver targeted biological responses:

• Red (635nm): Activates Complex IV, boosts ATP, reduces inflammation via IL-10

• Green (520–532nm): Targets Complex III, stimulates stem cells, collagen, and tissue repair

• Violet (405nm): Engages Complexes I & II, supports vagus nerve, immunity, and microbial defence

Together, these wavelengths offer a multi-layered systemic reset for cellular health.

Backed by Science, Not Hype

Erchonia holds 22 FDA 510(k) clearances—more than any other laser company—each supported by double-blind, placebo-controlled clinical trials. This evidence-led approach sets the standard for therapeutic integrity in wellness.

Inside the FX & Handheld Portfolio

• FX Series: Dual-wavelength (red + violet), hands-free system for energy, inflammation, and recovery

• XLR8: Red diode foundational tool for tissue repair and energy production

• EVRL: Red and violet laser for immune, microbial, and neurohormonal support

• GVL: Green and violet diode laser, FDA-cleared for pain and inflammation

Voices From The Field

Dr Rita Rakus, Aesthetic Practitioner:
“The FX Series and handheld lasers reflect a shift toward true cellular renewal—a future rooted in mitochondrial science.”

Dr Erik Reis, Chiropractic Neurologist, USA:
“Just as sunlight powers plants, Erchonia’s lasers energise human cells—non-invasively, without heat or drugs.”

Key Areas of Application

• Cognitive Function: Focus, clarity, and mood

• Hormonal Resilience: Perimenopause, menopause, neuroendocrine support

• Longevity: Enhanced mitochondrial vitality and adaptive capacity

• Nervous System Support: Including vagus nerve and neuroimmune synchrony

• Regeneration & Aesthetics: Circulation, tissue recovery, post-procedure outcomes

About Erchonia

With over 25 years of research into non-thermal laser therapy, Erchonia has pioneered multiple industry firsts, including the FDA’s first clearance for non-invasive fat loss lasers in 2010. Their green laser—proven in three separate double-blind clinical trials—delivers 23% more energy than red lasers and offers the safest, most effective way to treat fat.

Public figures such as Baroness Karren Brady are among those reported to have used Erchonia’s laser technologies.